A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting Conditions
NCT00864435
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Carvedilol 12.5 mg Tablets, single dose
DRUG:
Coreg® 12.5 mg Tablets , single dose
Sponsor
Actavis Inc.